Shreemandar Nandakumar Tambat
About Shreemandar Nandakumar Tambat
Data last updated:
Shreemandar Nandakumar Tambat is a Director at Progiene Formulations Private Limited (since 2021). The companies operate in Chemicals and Trading. Progiene Formulations Private Limited reported revenue of ₹2.8 Lakh (FY 2022). Earlier, Shreemandar Nandakumar Tambat was a Director at Prognogen Global Healthcare Private Limited (2022–2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Progiene Formulations Private Limited U24299PN2021PTC205052 | Director | 08 Oct 2021 | 2021 | ₹2.8 Lakh (FY 2022) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Prognogen Global Healthcare Private Limited U51909PN2022PTC214669 | Director | 12 Sep 2022 | 2022 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Shreemandar Nandakumar Tambat
| Name | DIN | Company | Designation |
|---|---|---|---|
| Suresh Mali | 09089736 | Progiene Formulations Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shreemandar Nandakumar Tambat
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shreemandar Nandakumar Tambat
Shreemandar Nandakumar Tambat currently holds 1 directorship: Progiene Formulations Private Limited (Director, since 08 Oct 2021, revenue ₹2.8 Lakh (FY 2022)).
Shreemandar Nandakumar Tambat was first appointed on 08 Oct 2021 as Director at Progiene Formulations Private Limited. The most recent appointment on record is 12 Sep 2022 at Prognogen Global Healthcare Private Limited.
Shreemandar Nandakumar Tambat held 1 earlier board appointment: Prognogen Global Healthcare Private Limited (Director, 12 Sep 2022 to 07 May 2024).
The current boards of Shreemandar Nandakumar Tambat's companies include Suresh Mali (Progiene Formulations Private Limited).